• OPEN AN ACCOUNT
Indian Indices
Sensex
81,592.45 -318.56
( -0.39%)
Global Indices
Nasdaq
52,431.30 -76.19
(-0.15%)
Dow Jones
7,621.14 -19.24
(-0.25%)
Hang Seng
61,109.24 289.88
(0.48%)
Nikkei 225
10,863.06 27.59
(0.25%)
Forex
USD-INR
93.72 0.15
(0.16%)
EUR-INR
104.27 -0.51
(-0.49%)
GBP-INR
124.72 -0.66
(-0.52%)
JPY-INR
0.59 0.00
(-0.43%)

EQUITY - MARKET SCREENER

Sarda Energy & Minerals Ltd
Industry :  Steel - Medium / Small
BSE Code
ISIN Demat
Book Value()
504614
INE385C01021
202.5047508
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SARDAEN
19.31
15779.63
EPS(TTM)
Face Value()
Div & Yield %
23.19
1
0.45
 

Laurus Labs board approves acquisition of 60% stake in Galenvs Sciences Inc.
Oct 29,2026
The board of Laurus Labs at its meeting held on 29 October 2026 has approved for acquisition of 60% share capital of Galenvs Sciences Inc. (Galenvs), a Canada based company, at a pre-money valuation of USD 3.50 million. The company proposes to invest a total of USD 3.75 million, which includes primary infusion of USD 2.75 million and a secondary acquisition of USD 1.00 million.

Galenvs is a contract research and development organization (CRO/ CDMO) specializing in custom oligonucleotide synthesis and functional magnetic-nanoparticle (MNP) technologies for the diagnostics and therapeutics markets. It operates a vertically integrated platform spanning discovery, optimization, synthesis, purification, validation and pilot-scale production.